Synapse - Dana Rathkopf

Results (274)

National cancer system characteristics and prostate cancer outcomes: An analysis of global data

Journal Article

Dee, E. C.; Iyengar, R.; Narayan, A.; Feliciano, E. J. G.; Wu, J. F.; Ho, F. D. V.; Ng, K.; Willmann, J.; Cabaero, M. L. L.; Tan, A. K. N. G.; more...
Prostate (2025)

Fulltext@MSK | Save

rechARge: A randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator’s choice in patients with mCRPC

Journal Article

Chi, K. N.; McKay, R. R.; Sandhu, S.; Arranz, J. A.; Barthélémy, P.; Hadaschik, B.; Matsubara, N.; Shore, N. D.; Ye, D.; Cascella, T.; more...
Future Oncology (2025)

Fulltext@MSK | Save

Olaparib and durvalumab in patients with DNA damage repair alterations and biochemically recurrent prostate cancer

Journal Article

Autio, K. A.; McHugh, D. J.; Rathkopf, D. E.; Xiao, H.; Merugu, S.; Wong, P.; Jan, M.; Dorff, T. B.; Heath, E. I.; Scher, H. I.
Journal of Immunotherapy and Precision Oncology (2025)

Fulltext@MSK | Save

High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes

Journal Article

Sharifi, M. N.; Sperger, J. M.; Taylor, A. K.; Tippins, K. E.; Reese, S. R.; Carreno, V.; Kaufmann, K. R.; Chang, A. H.; Nunamaker, L. A.; Linebarger, C.; more...
Cancer Discovery (2025)

Fulltext@MSK | Save

Relationship between undetectable PSA nadir and outcomes for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in IRONMAN, the International Registry for Men with Advanced Prostate Cancer

Meeting Abstract

McManus, H. D.; Howard, L.; Crowell, K. A.; Hyslop, T.; Autio, K. A.; Rathkopf, D.; Dreicer, R.; Chi, K. N.; Ong, M.; Mateo, J.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Deep prostate-specific antigen (PSA) decline among early participants (pts) in LIBERTAS, a phase 3 study of apalutamide (APA) plus continuous versus intermittent androgen deprivation therapy (ADT) in metastatic castration-sensitive prostate cancer (mCSPC)

Meeting Abstract

Azad, A.; Badillo, M. A.; Dong, Q.; Morgans, A. K.; Rathkopf, D.; Runcie, K.; Zhang, T.; Gotto, G.; Merseburger, A. S.; Dos Santos, A.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer

Editorial

Chi, K. N.; Rathkopf, D.; Smith, M. R.; Efstathiou, E.; Attard, G.; Olmos, D.; Lee, J. Y.; Small, E. J.; Pereira de Santana Gomes, A. J.; Roubaud, G.; more...
Future Oncology (2025)

Fulltext@MSK | Save

Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Journal Article

Gillessen, S.; Turco, F.; Davis, I. D.; Efstathiou, J. A.; Fizazi, K.; James, N. D.; Shore, N.; Small, E.; Smith, M.; Sweeney, C. J.; more...
European Urology (2025)

Fulltext@MSK | Save

Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer